首页 | 官方网站   微博 | 高级检索  
     

中国地区COVID-19 康复者SARS-CoV-2 特异性抗体IgG 阳性率动态变化的meta 分析
引用本文:许 涛a,高玉芳a,刘振社a,权 伟,杨 磊b.中国地区COVID-19 康复者SARS-CoV-2 特异性抗体IgG 阳性率动态变化的meta 分析[J].现代检验医学杂志,2022,0(6):134-139.
作者姓名:许 涛a  高玉芳a  刘振社a  权 伟  杨 磊b
作者单位:(1. 咸阳市中心医院 a. 检验科;b. 生殖医学科,陕西咸阳 712000;2. 海原县人民医院检验科,宁夏海原 755200)
摘    要:目的 了解中国地区新型冠状病毒病(coronavirus disease 2019,COVID-19)康复者严重急性呼吸综合征冠状病毒2(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)特异性抗体IgG 阳性率的动态变化。方法 计算机检索PubMed,Embase,中国知网(CNKI)、万方数据库和维普数据库(VIP)中有关中国地区COVID-19 康复者SARS-CoV-2 特异性抗体IgG 阳性率检测相关文献,检索时间为2019 年12 月~ 2022 年2 月24 日。根据修改后的AHRQ (Agency for Healthcare Researoh and Quality, 美国卫生保健质量和研究机构) 标准评估文献质量。采用Freeman-Tukey 双反正弦转换法计算阳性率,统计分析采用StataSE15.0 软件。根据检测方法、检测片段进行亚组分析,采用Egger 法检验发表偏倚。结果 共纳入12 篇文献,IgG 检测时间为感染SARS-CoV-2 后第1 个月~第12 个月,每个月样本量总计为74 ~ 2 907 例。第1 个月IgG 阳性率为81.10%(95%CI:75.76% ~ 85.87%),第2 个月和第3 个月阳性率最高,分别为96.35%(95%CI:93.98% ~ 98.14%)和97.23%(95%CI:94.47% ~ 99.05%),随时间推移阳性率逐渐下降,至第12 个月为73.63%(95%CI:50.31% ~ 91.45%)。亚组分析显示不同检测方法的研究间、不同检测片段的研究间阳性率差异均有统计学意义(χ2=5.02 ~ 39.57,均P< 0.05)。Egger 法检验发表偏倚为差异无统计学意义(t=1.85,P =0.101)。结论 大多数SARS-CoV-2 感染者一年后仍可检出SARS-CoV-2 特异性抗体IgG。

关 键 词:新型冠状病毒病  严重急性呼吸综合征冠状病毒2  特异性抗体IgG  Meta  分析

A Meta-analysis of Dynamic Change of the SARS-COV-2 Specific Antibody IgG Positive Rate in Convalescent Patients with COVID-19 in China
XU Taoa,GAO Yu-fanga,LIU Zhen-shea,QUAN Wei,YANG Leib.A Meta-analysis of Dynamic Change of the SARS-COV-2 Specific Antibody IgG Positive Rate in Convalescent Patients with COVID-19 in China[J].Journal of Modern Laboratory Medicine,2022,0(6):134-139.
Authors:XU Taoa  GAO Yu-fanga  LIU Zhen-shea  QUAN Wei  YANG Leib
Affiliation:(1a. Department of Clinical Laboratory; 1b. Department of Reproductive Medicine, Xianyang Central Hospital, Shaanxi Xianyang 712000, China; 2. Department of Clinical Laboratory, Haiyuan County People’s Hospital, Ningxia Haiyuan 755200, China)
Abstract:Objective To investigate the dynamic changes of severe acute respiratory syndrome coronavirus 2(SARS-COV-2) specific antibody IgG positive rate in coronavirus disease 2019(COVID-19) survivors in China. Methods the relevant literatures about the positive rate of SARS-COV-2 specific antibody IgG in COVID-19 survivors in China were retrieved from PubMed, Embase, CNKI, Wanfang database and VIP database from December 2019 to February 24, 2022. The quality of the documents were assessed according the revised AHRQ(Agency for Healthcare Research and Quality) statement. Freeman-tukey double arsinusoidal conversion method was used to calculate the positive rate, and StataSE15.0 software was used for statistical analysis. Subgroup analysis was performed according to detection method and fragment, and publication bias was examined by Egger method. Results A total of 12 articles were included, IgG was detected from the first month to the twelfth month after SARS-COV-2 infection, and the total sample size ranged from 74 to 2 907 cases per month. The positive rate was the highest in the second month and the third month, 96.35% (95%CI: 93.98% ~ 98.14%) and 97.23% (95%CI: 94.47% ~ 99.05%) respectively. The positive rate decreased gradually with time, and reached 73.63% (95%CI: 50.31% ~ 91.45%) in the twelfth month. The results of subgroup analysis showed that the heterogeneity between studies with the different detection method and the different detection fragment were significant differences(χ2=5.02 ~ 39.57, all P<0.05). Egger method test published bias, and the difference was not statistically significant (t=1.85, P=0.101). Conclusion Most people , one year after infection with SARSCOV- 2, could still detect SARS-COV-2 specific antibody IgG.
Keywords:
点击此处可从《现代检验医学杂志》浏览原始摘要信息
点击此处可从《现代检验医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号